Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Head and Neck Cancer

Free Subscription 06.04.2026 1 Am J Gastroenterol 1 Ann Otol Rhinol Laryngol 2 Anticancer Res 1 BMC Cancer 1 Br J Cancer 1 Br J Oral Maxillofac Surg 3 Clin Cancer Res 8 Clin Nucl Med 3 Dis Esophagus 1 Gastrointest Endosc 3 Head Neck 1 Histopathology 2 HNO 2 J Oral Maxillofac Surg 1 Laryngoscope 3 Oral Oncol 9 Otolaryngol Head Neck Surg 2 PLoS One 2 Radiother Oncol 1 Surgery 15 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. CODIPILLY DC, Faghani S, Vogelsang D, Moassefi M, et al
   Deep Learning Model for Histologic Diagnosis of Dysplastic Barrett's Esophagus: Multisite Cohort External Validation.
   Am J Gastroenterol. 2026;121:863-870.
   PubMed         Abstract available
   
   

   
   Ann Otol Rhinol Laryngol

2. YOUNG K, Ghias AF, Fancher N, Ahn HJ, et al
   Limitations of PET/CT in Detecting Cervical Lymph Node Metastases in Betel Nut Induced Oral Cancer.
   Ann Otol Rhinol Laryngol. 2026 Mar 30:34894261427917.
   PubMed         Abstract available
   
   

   
   Anticancer Res

3. YU AM, O'Toole TR, Lai J
   Transoral Robotic Surgery for High Grade Oropharyngeal Mucoepidermoid Carcinoma With Good Outcome and Preserved Oropharyngeal Functions.
   Anticancer Res. 2026;46:2285-2289.
   PubMed         Abstract available
   
   
4. FUJISAWA T, Makita K, Nakamura M, Hirata H, et al
   Clinical Outcomes of the Optimized Weekly 8-Gy Palliative Radiotherapy Regimen.
   Anticancer Res. 2026;46:2133-2144.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. ZHU L, Zeng F, Chen K, Li L, et al
   Impact of concurrent chemotherapy dose on long-term survival in locally advanced nasopharyngeal carcinoma: a 10-year single-center study.
   BMC Cancer. 2026 Mar 28. doi: 10.1186/s12885-026-15873.
   PubMed        
   
   

   
   Br J Cancer

6. GUO WP, Yu X, Lu ZJ, Li YC, et al
   Incorporating early cfEBV DNA clearance into clinical risk stratification to tailor induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma.
   Br J Cancer. 2026 Mar 31. doi: 10.1038/s41416-026-03401.
   PubMed         Abstract available
   
   

   
   Br J Oral Maxillofac Surg

7. NAIR A, Falls D, Wilson A, Nugent M, et al
   Comment on "Lateralised T3/T4N0 oral squamous cell carcinoma. Is contralateral elective neck dissection or neck radiotherapy indicated? A multicentre retrospective study" [BJOMS 63(7) https://doi.org/10.1016/j.bjoms.2025.04.007].
   Br J Oral Maxillofac Surg. 2026 Mar 18:S0266-4356(26)00045.
   PubMed        
   
   

   
   Clin Cancer Res

8. JIANG L, Li X, Ma T, Zeng P, et al
   Clinical Significance for risk stratification of papillary thyroid cancer by TUMORFISHER circulating tumor cells technique.
   Clin Cancer Res. 2026 Jan 16. doi: 10.1158/1078-0432.CCR-25-2694.
   PubMed         Abstract available
   
   
9. VEMULAMANDA S, Kothari A, De Cecco L, Kim S, et al
   Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.
   Clin Cancer Res. 2026 Apr 1. doi: 10.1158/1078-0432.CCR-25-2159.
   PubMed         Abstract available
   
   
10. CAI J, Zhao B, Ji D, Zhou F, et al
    LM-101, an anti-SIRPalpha antibody, in patients with relapsed/refractory lymphoma and advanced head and neck cancer: an open-label, multicenter, phase 1 trial.
    Clin Cancer Res. 2026 Mar 30. doi: 10.1158/1078-0432.CCR-25-2357.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

11. KUMAR SA, Srinivasan AA, Srinivas BH, Sethi P, et al
    Rampant Cystic Metastases From Oral Squamous Cell Carcinoma on 18F-FDG PET/CT: A Rare Clinical Presentation Showing Interplay of Inflammation and Malignancy.
    Clin Nucl Med. 2025 Aug 25. doi: 10.1097/RLU.0000000000006111.
    PubMed         Abstract available
    
    
12. NARAYANAN S, Kumar SA, Goyal H, Halanaik D, et al
    Adenocarcinoma Arising in an Esophageal Duplication Cyst With Disseminated Metastases: A Rare Case Detected on 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Sep 10. doi: 10.1097/RLU.0000000000006135.
    PubMed         Abstract available
    
    
13. SABER TANHA A, Jafari Zarrin Ghabaei F, Raeisi N, Aryana K, et al
    FAPI-Based Theranostics in Medullary Thyroid Cancer: A Viable Alternative When Somatostatin Receptor-Based Theranostics Show Limited Efficacy-A Clinical Experience.
    Clin Nucl Med. 2025 Oct 30. doi: 10.1097/RLU.0000000000006127.
    PubMed         Abstract available
    
    
14. RAEISI N, Saber Tanha A, Kamali H, Aryana K, et al
    99m Tc-FAPI Scintigraphy in Metastasis Workup of Sinonasal Rhabdomyosarcoma; Unveiling Diffuse Bone Marrow Involvement.
    Clin Nucl Med. 2026;51:e334-e335.
    PubMed         Abstract available
    
    
15. THAKUR S, Raju S, Rajguru R, Chowhan AK, et al
    Dual-Tracer PET/CT in Erysipelas-like Cutaneous Metastases From Salivary Duct Adenocarcinoma: FAPI Illuminates What FDG Missed.
    Clin Nucl Med. 2025 Dec 23. doi: 10.1097/RLU.0000000000006253.
    PubMed         Abstract available
    
    
16. CHENG K, Ding H, Guo X, Liu H, et al
    Increased Uptake of 68 Ga-DOTA-IBA in Polymorphous Adenocarcinoma of the Parotid Gland.
    Clin Nucl Med. 2026;51:446-447.
    PubMed         Abstract available
    
    
17. DEMIRKOL MO, Kaya G, Seymen H, Alagol F, et al
    Restoring Radioiodine Avidity in Radioiodine-refractory Differentiated Thyroid Cancer With Genotype-guided MAPK Inhibition and Dosimetry-guided Radioiodine.
    Clin Nucl Med. 2026 Feb 4. doi: 10.1097/RLU.0000000000006362.
    PubMed         Abstract available
    
    
18. OKUDAN B, Albayrak A, Seven B, Ceran F, et al
    Tongue Uptake of 18F-FDG on PET/CT Mimicking Malignancy.
    Clin Nucl Med. 2026;51:454-455.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

19. DE OLIVEIRA JF, Martins BC, Moura RN, de Paulo GA, et al
    Randomized trial of intralesional steroid injection versus oral prednisolone for preventing esophageal stricture after extensive endoscopic submucosal dissection.
    Dis Esophagus. 2026;39:doag027.
    PubMed         Abstract available
    
    
20. ZALEWSKI A, Lin DC, Lo AA, Yang GY, et al
    Increased prevalence of esophageal squamous cell papilloma in eosinophilic esophagitis: incidental finding or disease related consequence?
    Dis Esophagus. 2026;39:doag022.
    PubMed         Abstract available
    
    
21. ISHIYAMA K, Nozaki R, Kakuta R, Igaue S, et al
    Short- and long-term outcomes of conversion minimally invasive esophagectomy versus open approach following induction therapy in cT4b esophageal cancer.
    Dis Esophagus. 2026;39:doag025.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

22. DAI N, Guo C, Liu P, Zhang F, et al
    Clinical Outcomes of Circumferential Endoscopic Submucosal Dissection for Superficial Esophageal Squamous Cell Carcinoma: A Retrospective Study.
    Gastrointest Endosc. 2026 Mar 26:S0016-5107(26)00216.
    PubMed         Abstract available
    
    

    
    Head Neck

23. HOSHI Y, Kuno H, Sakashita S, Hiyama T, et al
    Significance of Preoperative Imaging-Detected Extranodal Extension in Pathological Extranodal Extension-Positive Head and Neck Squamous Cell Carcinoma Treated With Postoperative Chemoradiotherapy.
    Head Neck. 2026 Apr 3. doi: 10.1002/hed.70256.
    PubMed         Abstract available
    
    
24. CAPIK O, Tekman S, Gundogdu B, Kilic A, et al
    CCL26-Mediated Modulation of Endothelial Secretome by Hypoxia-Induced Tumor-Derived Exosomes Enhances Metastatic Progression in Head and Neck Cancer.
    Head Neck. 2026 Apr 3. doi: 10.1002/hed.70259.
    PubMed         Abstract available
    
    
25. GREEN JB, Ihrig IC, King TS, Moreno MG, et al
    Radiofrequency Ablation of Low-Risk Primary Papillary Thyroid Carcinoma in a Clinic Setting.
    Head Neck. 2026 Apr 1. doi: 10.1002/hed.70246.
    PubMed         Abstract available
    
    

    
    Histopathology

26. ANDRE E, Mebarki L, Ilie M, Subtil F, et al
    Validating the 2022 WHO classification in thyroid carcinomas: Prospective evidence for predicting iodine resistance.
    Histopathology. 2026 Mar 28. doi: 10.1111/his.70148.
    PubMed         Abstract available
    
    

    
    HNO

27. VAHL JM, Denkinger MD, von Witzleben A, Laban S, et al
    [Outcome of the geriatric head and neck cancer patient].
    HNO. 2026 Mar 31. doi: 10.1007/s00106-026-01750.
    PubMed         Abstract available
    
    
28. KURTEN CHL, Peis T, Boosfeld L, Peis M, et al
    [Immunology of aging in head and neck cancer : From the tumor microenvironment to translational approaches and clinical response].
    HNO. 2026 Mar 31. doi: 10.1007/s00106-026-01757.
    PubMed         Abstract available
    
    

    
    J Oral Maxillofac Surg

29. WU K, Yang Z, Gong Z, Wu H, et al
    A New Classification of Buccal Mucosa Squamous Cell Carcinoma and the Corresponding Surgical Strategy.
    J Oral Maxillofac Surg. 2026;84:592-599.
    PubMed         Abstract available
    
    
30. KAVUTARAPU SK, Bylapudi B, Shiv Kumar K, Noothanapati NR, et al
    Reverse Flow Nasolabial Flap for Reconstruction of Palatomaxillary Defects: A Surgical Innovation and Outcomes.
    J Oral Maxillofac Surg. 2026;84:600-607.
    PubMed         Abstract available
    
    

    
    Laryngoscope

31. CHUA NYM, Chan YH, Loh WS, Wang Y, et al
    Radiotherapy-Induced Otitis Media With Effusion in Nasopharyngeal Carcinoma: A Meta-Analysis.
    Laryngoscope. 2026 Apr 1. doi: 10.1002/lary.70535.
    PubMed         Abstract available
    
    

    
    Oral Oncol

32. LI J
    Sex-specific immune determinants in head and neck squamous cell carcinoma: bridging preclinical insights to clinical translation.
    Oral Oncol. 2026;176:107950.
    PubMed        
    
    
33. MASCARELLA MA, Mlynarek A, Richardson K, Vendra V, et al
    Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.
    Oral Oncol. 2026;176:107943.
    PubMed         Abstract available
    
    
34. YAMADA T, Okuyama K, Hamada A, Yanamoto S, et al
    Interpreting neoadjuvant chemo-immunotherapy through tumor microenvironment dynamics in head and neck cancer.
    Oral Oncol. 2026;176:107958.
    PubMed        
    
    

    
    Otolaryngol Head Neck Surg

35. SCHARNER MK, Walker AM, Nguyen SA, Kejner AE, et al
    Topical Imiquimod for Oral Cavity Leukoplakia and Dysplasia: A Scoping Review.
    Otolaryngol Head Neck Surg. 2026;174:863-870.
    PubMed         Abstract available
    
    
36. SAMPIERI C, Mora F, Peretti G, Larrosa M, et al
    Multicenter Clinical Validation of an Artificial Intelligence Diagnostic Classification Model for Laryngoscopy Images.
    Otolaryngol Head Neck Surg. 2026;174:1049-1058.
    PubMed         Abstract available
    
    
37. TANG A, Helou V, Sridharan SS, Ferrarotto R, et al
    Contemporary Management of Malignancies of the Parotid Gland: A State-of-the-Art Review.
    Otolaryngol Head Neck Surg. 2026;174:916-932.
    PubMed         Abstract available
    
    
38. CARAWAY J, Millay D, Zarrella D, Kim HE, et al
    Intraoperative Margin Assessment Methods in Oral Cavity Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Otolaryngol Head Neck Surg. 2026;174:881-891.
    PubMed         Abstract available
    
    
39. ELWELL Z, Narendran NH, Gallego CJ, Davis K, et al
    Geographic Disparities in Sinonasal Masses: A Single Institution Experience.
    Otolaryngol Head Neck Surg. 2026;174:1039-1048.
    PubMed         Abstract available
    
    
40. USECHE M, Alkhatib HH, Rodriguez CP, Shih L, et al
    Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early-Onset Oral Cavity Cancer.
    Otolaryngol Head Neck Surg. 2026;174:1025-1038.
    PubMed         Abstract available
    
    
41. RODRIGANEZ L, Gomez-Camacho H, Castro A, Del Palacio A, et al
    Open Partial Horizontal Laryngectomies: Functional and Oncologic Outcomes.
    Otolaryngol Head Neck Surg. 2026;174:1010-1017.
    PubMed         Abstract available
    
    
42. BULBUL MG, de Almeida JR, Gross ND, Turner MT, et al
    Treatment of P16-Negative/HPV-Negative Oropharyngeal Squamous Cell Carcinoma: A Survey of AHNS Membership.
    Otolaryngol Head Neck Surg. 2026;174:1018-1024.
    PubMed         Abstract available
    
    
43. TONG JY, Bzhilyanskaya V, Molitoris JK, Ferris MJ, et al
    Does Smoking Influence Outcomes in Human Papillomavirus-Associated Oropharyngeal Cancer Treated with Transoral Robotic Surgery?
    Otolaryngol Head Neck Surg. 2026;174:1003-1009.
    PubMed         Abstract available
    
    

    
    PLoS One

44. BAYLEY JP, Rebel HG, Devilee P
    A novel genetic strategy to interrogate an unknown phenotypic modifier: Sdhc KO-Robertsonian mice develop frequent thyroid abnormalities with papillary thyroid carcinoma-like features.
    PLoS One. 2026;21:e0336731.
    PubMed         Abstract available
    
    
45. CHEN H, Ruan F, Zhu L, Zhuang Y, et al
    Utilizing the transformer mechanism to predict cervical lymph node metastasis in patients with papillary thyroid carcinoma.
    PLoS One. 2026;21:e0345937.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

46. EIDE HA, Grut H, Jebsen P, Kyte JA, et al
    Hyperfractionated reirradiation and PD-1 blockade in recurrent squamous cell head and neck carcinomas with poor prognosis, results from the REPORT-trial.
    Radiother Oncol. 2026 Mar 29:111514. doi: 10.1016/j.radonc.2026.111514.
    PubMed         Abstract available
    
    
47. POINTREAU Y, Larnaudie A, Sun XS, Rolland F, et al
    Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022-01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatin.
    Radiother Oncol. 2026;219:111479.
    PubMed         Abstract available
    
    

    
    Surgery

48. LIU R, Weldon CB, Trosman JR, Fong B, et al
    Improving timing and sequencing of postoperative radiation therapy in head and neck cancer.
    Surgery. 2026;194:110147.
    PubMed         Abstract available
    
    

    
    Thyroid

49. YEH MW
    Omitting Radioactive Iodine after Therapeutic Lateral Neck Dissection May Be the Next Step in De-Escalating Initial Treatment of Papillary Thyroid Cancer.
    Thyroid. 2026;36:1-2.
    PubMed        
    
    
50. SHEN K, Liu Y, Tan M, Yan S, et al
    Long-Term Scar Perception and Quality of Life After Open Thyroidectomy in Chinese Patients: A Cross-Sectional Survey Study.
    Thyroid. 2025 Nov 24. doi: 10.1177/10507256251398414.
    PubMed         Abstract available
    
    
51. DE STEFANO MA, Luongo C, Porcelli T, Cervone C, et al
    Type 2 Deiodinase in Cancer-Associated Fibroblasts is Required to Sustain Growth of Poorly and Undifferentiated Thyroid Cancer.
    Thyroid. 2025 Nov 27. doi: 10.1177/10507256251401458.
    PubMed         Abstract available
    
    
52. TAPROGGE J, Murray I, Newbold K, Garcez K, et al
    A Systematic Review of Absorbed Doses and Response in Patients Treated with Radioiodine for Differentiated Thyroid Cancer.
    Thyroid. 2025 Nov 24. doi: 10.1177/10507256251396454.
    PubMed         Abstract available
    
    
53. LIAO J, Song J, Wang Z, Xing M, et al
    Functional Loss of the Tumor Suppressor Gene RASAL1 Through Formation of Aberrant Splice Variant RASAL1-004 as a Novel Oncogenic Mechanism in Thyroid Cancer.
    Thyroid. 2025 Dec 22. doi: 10.1177/10507256251401486.
    PubMed         Abstract available
    
    
54. KIM M, Lee EK, Kim KJ, Shin SM, et al
    Thyroglobulin Cutoffs after Total Thyroidectomy Without Radioiodine in Low- to Intermediate-Risk Thyroid Cancer: A Multicenter Cohort Study.
    Thyroid. 2025 Dec 23. doi: 10.1177/10507256251409134.
    PubMed         Abstract available
    
    
55. LAW LS, Kuu NWX, Leong MHT, Yeoh SF, et al
    Subcutaneous Levothyroxine Administration in Treatment of Refractory Primary Hypothyroidism: A Case Report.
    Thyroid. 2025 Dec 17. doi: 10.1177/10507256251409071.
    PubMed         Abstract available
    
    
56. YANG W, Skan O, Rogers SN, Wheelwright S, et al
    Understanding the Factors That Influence Shared-Decision Making Around Surgical Resection of Low-Risk Thyroid Cancers: A Prospective Qualitative Study.
    Thyroid. 2025 Dec 18. doi: 10.1177/10507256251408856.
    PubMed         Abstract available
    
    
57. ZHU L, Jiang K, Huang J, Zhang Q, et al
    DNA Hypermethylation Suppresses Thyroid Peroxidase Expression and May Be a Promising Diagnostic Marker for Thyroid Cancer.
    Thyroid. 2026 Mar 4:10507256261427034. doi: 10.1177/10507256261427034.
    PubMed         Abstract available
    
    
58. HUANG J, Chen W, Zhang J, Xu H, et al
    The Effect of Standardized Postoperative Neck and Orofacial Rehabilitation Exercise on Quality of Life in Post-Thyroidectomy Patients: A Randomized Controlled Trial.
    Thyroid. 2026 Mar 4:10507256261427761. doi: 10.1177/10507256261427761.
    PubMed         Abstract available
    
    
59. NA DG, Noh BJ, Kim WJ, Kim JY, et al
    Diagnostic Performance of Five Societies' Ultrasound Risk Stratification Systems for Thyroid Malignancy According to Nodule Size: A Comparison Using a Standardized Ultrasound Lexicon.
    Thyroid. 2026 Mar 6:10507256261429117. doi: 10.1177/10507256261429117.
    PubMed         Abstract available
    
    
60. WU J, Yeo C, Qi J, Ghaznavi S, et al
    Outcomes of Patients with RAS-Positive Bethesda III and IV Cytology Thyroid Nodules.
    Thyroid. 2026 Mar 6:10507256261429119. doi: 10.1177/10507256261429119.
    PubMed         Abstract available
    
    
61. COMESS SR, Kapustin JE, Nurimba M, Kwon I, et al
    MarginView3D: Extending Novel 3D Surgical Pathology Reporting for Use in Invasive pT4 Thyroid Cancer and Other Surgical Oncologic Procedures.
    Thyroid. 2026 Mar 9:10507256261431842. doi: 10.1177/10507256261431842.
    PubMed         Abstract available
    
    
62. SAWKA AM, Ghai S, Rotstein L, Irish JC, et al
    Patient-Reported Outcomes Three Years After Deciding on Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: Results of a Prospective Cohort Study.
    Thyroid. 2026 Mar 12:10507256251408857. doi: 10.1177/10507256251408857.
    PubMed         Abstract available
    
    
63. KANG YE, Cho CH, Song M, Lee JH, et al
    The Patterns and Risk Factors for Antidepressant Drug Prescription in Thyroid Cancer Patients and Survivors: Analysis Based on the Korean National Health Insurance Service Database.
    Thyroid. 2026 Mar 17:10507256261431793. doi: 10.1177/10507256261431793.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum